InfuSystem Holdings INFU Patient Services and Device Solutions — Lease revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by InfuSystem Holdings in its filing.
Tagged under the XBRL concept us-gaap:LeaseIncome.
The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InfuSystem Holdings's patient services and device solutions — lease revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is InfuSystem Holdings's patient services and device solutions — lease revenue?
- InfuSystem Holdings (INFU) reported patient services and device solutions — lease revenue of $7.42M in Q1 2026.
- How has InfuSystem Holdings's patient services and device solutions — lease revenue changed year-over-year?
- InfuSystem Holdings's patient services and device solutions — lease revenue decreased by 4.8% year-over-year, from $7.79M to $7.42M.
- What is the long-term trend for InfuSystem Holdings's patient services and device solutions — lease revenue?
- Over 4 years (2021 to 2025), InfuSystem Holdings's patient services and device solutions — lease revenue has grown at a 8.8% compound annual growth rate (CAGR), from $21.68M to $30.36M.
- What does patient services and device solutions — lease revenue mean?
- This metric captures the revenue generated specifically from the leasing of durable medical equipment to healthcare providers and patients. It reflects the recurring nature of the company's revenue stream derived from equipment utilization rather than one-time sales. Monitoring this metric helps investors assess the stability and predictability of cash flows generated by the company's asset-based service model.